Marshall Wace, LLP Co Diagnostics, Inc. Transaction History

Marshall Wace, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $1.8 Million - $2.29 Million	-221,292 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.48 - $11.38 $1.39 Million - $2.12 Million	185,923 Added 525.67%	221,292 $2.15 Million
Q2 2021 Aug 13, 2021	BUY	$7.16 - $9.56 $253,242 - $338,127	35,369 New	35,369 $292,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.